Please enable JavaScript to continue using this application.

Compare $CATX vs $CYPH | Chartloom

Compare

$CATX vs $CYPH

Perspective Therapeutics Inc · Cypherpunk Technologies Inc

CATX

Perspective Therapeutics Inc

CYPH

Cypherpunk Technologies Inc

Compare $CATX vs $CYPH

Comparing Perspective Therapeutics Inc and Cypherpunk Technologies Inc

CATXPerspective Therapeutics Inc

CYPHCypherpunk Technologies Inc

CATXPerspective Therapeutics Inc

Market cap

$303M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-66.9%

YTD performance

-4.7%

52W performance

-31.1%

FCF yield

-40.0%

CYPHCypherpunk Technologies Inc

Market cap

$313M

P/E (TTM)

—

Forward P/E (NTM)

26.20x

Forward P/S (NTM)

6.06x

Rev growth (TTM)

—

YTD performance

160.2%

52W performance

292.0%

FCF yield

-11.1%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CATX

CYPH

Detailed metrics comparison

CATX

Perspective Therapeutics Inc

CYPH

Cypherpunk Technologies Inc

Market Cap

CATX$303M

CYPH$313M

Enterprise Value

CATX$256M

CYPH$305M

Price

CATX$2.66

CYPH$2.94

P/E Ratio

CATXN/A

CYPHN/A

P/S Ratio

CATX741.74x

CYPH217.68x

EV/Sales

CATX627.10x

CYPH0.00x

EV/EBITDA

CATX0.00x

CYPH0.00x

P/B Ratio

CATX0.97x

CYPH2.34x

P/FCF Ratio

CATXN/A

CYPHN/A

EV/FCF

CATX-2.11x

CYPH-8.83x

PEG Ratio

CATXN/A

CYPHN/A

Forward P/E (NTM)

CATXN/A

CYPH26.20x

Forward P/S (NTM)

CATXN/A

CYPH6.06x

Revenue (TTM)

CATX$409K

CYPH$0

Revenue Growth (YoY)

CATX-66.9%

CYPHN/A

Forward Rev Growth

CATX32.5%

CYPH155.2%

Gross Margin (TTM)

CATX23.0%

CYPH0.0%

Operating Margin (TTM)

CATX0.0%

CYPH0.0%

EBITDA Margin (TTM)

CATX-29628.1%

CYPH0.0%

Net Margin (TTM)

CATX-28468.0%

CYPH0.0%

FCF Margin (TTM)

CATX-29657.2%

CYPHN/A

Net Income (TTM)

CATX$-116M

CYPH$-877K

FCF (TTM)

CATX$-121M

CYPH$-35M

EPS (TTM)

CATX-$0.97

CYPH-$0.00

ROE (TTM)

CATX-4156.0%

CYPH-92.0%

ROA (TTM)

CATX-3413.0%

CYPH-87.0%

ROIC (TTM)

CATX-4132.0%

CYPH-92.0%

Cash

CATX$48M

CYPH$8M

Debt

CATX$2M

CYPH$0

Net Cash/Debt

CATX$47M

CYPH$8M

Current Ratio (TTM)

CATX6.61x

CYPH79.19x

Quick Ratio (TTM)

CATX6.49x

CYPH78.88x

Debt/Equity (TTM)

CATX0.00x

CYPH0.00x

Debt/Assets (TTM)

CATX0.0%

CYPH0.0%

Interest Coverage (TTM)

CATXN/A

CYPHN/A

Net Debt/EBITDA (TTM)

CATX0.00x

CYPH0.00x

Beta

CATX1.87

CYPH1.13

52W Performance

CATX-31.1%

CYPH292.0%

YTD Performance

CATX-4.7%

CYPH160.2%

% from 52W High

CATX-56.8%

CYPH-29.8%

% from 52W Low

CATX35.7%

CYPH648.1%

Asset Turnover (TTM)

CATX0.00x

CYPH0.02x

FCF Yield (TTM)

CATX-40.0%

CYPH-11.1%

Earnings Yield (TTM)

CATX-38.4%

CYPH-0.3%

Dividend Yield (TTM)

CATXN/A

CYPHN/A

Rule of 40

CATX-29,724.1

CYPH0.0

EV/GP/RG

CATX22.31

CYPHN/A

Ticker research

View CATX research View CYPH research

Metric	CATX Perspective Therapeutics Inc	CYPH Cypherpunk Technologies Inc
Market & Valuation
Market Cap	$303M	$313M
Enterprise Value	$256M	$305M
Price	$2.66	$2.94
P/E Ratio	N/A	N/A
P/S Ratio	741.74x	217.68x
EV/Sales	627.10x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.97x	2.34x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.11x	-8.83x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	26.20x
Forward P/S (NTM)	N/A	6.06x
Revenue & Growth
Revenue (TTM)	$409K	$0
Revenue Growth (YoY)	-66.9%	N/A
Forward Rev Growth	32.5%	155.2%
Profitability
Gross Margin (TTM)	23.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-29628.1%	0.0%
Net Margin (TTM)	-28468.0%	0.0%
FCF Margin (TTM)	-29657.2%	N/A
Net Income (TTM)	$-116M	$-877K
FCF (TTM)	$-121M	$-35M
EPS (TTM)	-$0.97	-$0.00
ROE (TTM)	-4156.0%	-92.0%
ROA (TTM)	-3413.0%	-87.0%
ROIC (TTM)	-4132.0%	-92.0%
Financial Health
Cash	$48M	$8M
Debt	$2M	$0
Net Cash/Debt	$47M	$8M
Current Ratio (TTM)	6.61x	79.19x
Quick Ratio (TTM)	6.49x	78.88x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.87	1.13
52W Performance	-31.1%	292.0%
YTD Performance	-4.7%	160.2%
% from 52W High	-56.8%	-29.8%
% from 52W Low	35.7%	648.1%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.02x
FCF Yield (TTM)	-40.0%	-11.1%
Earnings Yield (TTM)	-38.4%	-0.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-29,724.1	0.0
EV/GP/RG	22.31	N/A
Ticker research	View CATX research	View CYPH research

Valuation

P/S Ratio

CYPH

217.68x

CATX

741.74x

EV/FCF

CYPH

-8.83x

CATX

-2.11x

Growth & revenue

Revenue Growth TTM

CATX

-66.9%

Forward Revenue Growth

CYPH

155.2%

CATX

32.5%

Profitability & performance

Gross Margin

CATX

23.0%

CYPH

0.0%

ROE

CYPH

-92.0%

CATX

-4156.0%

FCF Yield %

CYPH

-11.1%

CATX

-40.0%

52-Week Performance

CYPH

292.0%

CATX

-31.1%

Detailed metrics comparison

CATX

Perspective Therapeutics Inc

CYPH

Cypherpunk Technologies Inc

Market Cap

CATX$303M

CYPH$313M

Enterprise Value

CATX$256M

CYPH$305M

Price

CATX$2.66

CYPH$2.94

P/E Ratio

CATXN/A

CYPHN/A

P/S Ratio

CATX741.74x

CYPH217.68x

EV/Sales

CATX627.10x

CYPH0.00x

EV/EBITDA

CATX0.00x

CYPH0.00x

P/B Ratio

CATX0.97x

CYPH2.34x

P/FCF Ratio

CATXN/A

CYPHN/A

EV/FCF

CATX-2.11x

CYPH-8.83x

PEG Ratio

CATXN/A

CYPHN/A

Forward P/E (NTM)

CATXN/A

CYPH26.20x

Forward P/S (NTM)

CATXN/A

CYPH6.06x

Revenue (TTM)

CATX$409K

CYPH$0

Revenue Growth (YoY)

CATX-66.9%

CYPHN/A

Forward Rev Growth

CATX32.5%

CYPH155.2%

Gross Margin (TTM)

CATX23.0%

CYPH0.0%

Operating Margin (TTM)

CATX0.0%

CYPH0.0%

EBITDA Margin (TTM)

CATX-29628.1%

CYPH0.0%

Net Margin (TTM)

CATX-28468.0%

CYPH0.0%

FCF Margin (TTM)

CATX-29657.2%

CYPHN/A

Net Income (TTM)

CATX$-116M

CYPH$-877K

FCF (TTM)

CATX$-121M

CYPH$-35M

EPS (TTM)

CATX-$0.97

CYPH-$0.00

ROE (TTM)

CATX-4156.0%

CYPH-92.0%

ROA (TTM)

CATX-3413.0%

CYPH-87.0%

ROIC (TTM)

CATX-4132.0%

CYPH-92.0%

Cash

CATX$48M

CYPH$8M

Debt

CATX$2M

CYPH$0

Net Cash/Debt

CATX$47M

CYPH$8M

Current Ratio (TTM)

CATX6.61x

CYPH79.19x

Quick Ratio (TTM)

CATX6.49x

CYPH78.88x

Debt/Equity (TTM)

CATX0.00x

CYPH0.00x

Debt/Assets (TTM)

CATX0.0%

CYPH0.0%

Interest Coverage (TTM)

CATXN/A

CYPHN/A

Net Debt/EBITDA (TTM)

CATX0.00x

CYPH0.00x

Beta

CATX1.87

CYPH1.13

52W Performance

CATX-31.1%

CYPH292.0%

YTD Performance

CATX-4.7%

CYPH160.2%

% from 52W High

CATX-56.8%

CYPH-29.8%

% from 52W Low

CATX35.7%

CYPH648.1%

Asset Turnover (TTM)

CATX0.00x

CYPH0.02x

FCF Yield (TTM)

CATX-40.0%

CYPH-11.1%

Earnings Yield (TTM)

CATX-38.4%

CYPH-0.3%

Dividend Yield (TTM)

CATXN/A

CYPHN/A

Rule of 40

CATX-29,724.1

CYPH0.0

EV/GP/RG

CATX22.31

CYPHN/A

Ticker research

View CATX research View CYPH research

Metric	CATX Perspective Therapeutics Inc	CYPH Cypherpunk Technologies Inc
Market & Valuation
Market Cap	$303M	$313M
Enterprise Value	$256M	$305M
Price	$2.66	$2.94
P/E Ratio	N/A	N/A
P/S Ratio	741.74x	217.68x
EV/Sales	627.10x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.97x	2.34x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.11x	-8.83x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	26.20x
Forward P/S (NTM)	N/A	6.06x
Revenue & Growth
Revenue (TTM)	$409K	$0
Revenue Growth (YoY)	-66.9%	N/A
Forward Rev Growth	32.5%	155.2%
Profitability
Gross Margin (TTM)	23.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-29628.1%	0.0%
Net Margin (TTM)	-28468.0%	0.0%
FCF Margin (TTM)	-29657.2%	N/A
Net Income (TTM)	$-116M	$-877K
FCF (TTM)	$-121M	$-35M
EPS (TTM)	-$0.97	-$0.00
ROE (TTM)	-4156.0%	-92.0%
ROA (TTM)	-3413.0%	-87.0%
ROIC (TTM)	-4132.0%	-92.0%
Financial Health
Cash	$48M	$8M
Debt	$2M	$0
Net Cash/Debt	$47M	$8M
Current Ratio (TTM)	6.61x	79.19x
Quick Ratio (TTM)	6.49x	78.88x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.87	1.13
52W Performance	-31.1%	292.0%
YTD Performance	-4.7%	160.2%
% from 52W High	-56.8%	-29.8%
% from 52W Low	35.7%	648.1%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.02x
FCF Yield (TTM)	-40.0%	-11.1%
Earnings Yield (TTM)	-38.4%	-0.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-29,724.1	0.0
EV/GP/RG	22.31	N/A
Ticker research	View CATX research	View CYPH research